pharmacodynamic Archives - FutureBridge
FutureBridge_TPD

TPDs – Potential to Turn Undruggable t...

Targeted Protein Degraders (TPDs) are pushing the boundaries of drug development by addressing previously untreatable targets. With 80% of TPDs in early stages, these therapies

Our Clients

Our long-standing clients include some of the worlds leading brands and forward-thinking corporations.